Cryo-Cell International Inc (CCEL) stock
Close on Nov 12, 2026Market cap $43.54MP/E –Yield –
Cryo-Cell International Inc saw revenue fall 2.0% to $31.13M over the twelve months to Aug 31, 2026. Operating income fell 95.6% to $189.42K, moving the operating margin from 13.6% to 0.6%. Free cash flow was $4.65M, down 24.8% from a year earlier. At the latest close the market valued the company at $43.54M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Aug 31, 2026
Valuation
- Market cap
- $43.54M
- P/E ratio
- –
- Price to sales
- 1.40
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- 10.68%
Fundamentals
- Revenue
- $31.13M
- Net income
- -$1.95M
- EPS, diluted
- -$0.24
- Free cash flow
- $4.65M
- Book value per share
- -$2.03
- Diluted shares
- 8M
Trading
- Previous close
- $5.14
- Open
- $5.04
- Day's range
- $4.97 – $5.44
- Volume
- 22,944
- Average volume (20 days)
- 8,439
- Beta (5 years)
- 0.29
- 52-week range
- $2.72 – $5.45
- RSI (14 days)
- 64.3
- Volatility (1 year)
- 74.9%
- Relative volume
- 1.16×
- WACC
- 8.2%
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | CCEL | S&P 500 | Difference | CCEL per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +20.0% | -2.7% | +22.7 pts | ||
| 3 months | +39.2% | -1.7% | +40.9 pts | ||
| Year to date | +57.0% | +11.9% | +45.1 pts | ||
| 1 year | +33.3% | +12.0% | +21.3 pts | ||
| 3 years | +14.8% | +78.2% | −63.4 pts | +4.7% | +21.2% |
| 5 years | -45.7% | +73.2% | −118.9 pts | -11.5% | +11.6% |
| 10 years | +70.4% | +309.6% | −239.2 pts | +5.5% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Cryo-Cell International filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- News
- News
- Results
- Update
About Cryo-Cell International
Services-Misc Health & Allied Services, NEC
Cryo-Cell International operates as a cellular processing and cryogenic storage company. It conducts business across three primary segments: cellular processing and cryogenic storage for family use, the manufacture of PrepaCyte CB processing system units, and cellular processing and cryogenic storage of cord blood stem cells for public use. The company collects, processes, and preserves stem cells derived from umbilical cord blood and cord tissue. Its principal clients are expectant parents seeking to preserve cellular materials for potential future medical treatments for their newborns or immediate family members.
Company profile, executives and historyCryo-Cell International stock: common questions
What is Cryo-Cell International's stock price?
CCEL closed at $5.40 on Nov 12, 2026, up 5.06% on the day. Over the past 52 weeks it traded between $2.72 and $5.45.
What is Cryo-Cell International's market cap?
Cryo-Cell International was worth $43.54M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is CCEL's P/E ratio?
Cryo-Cell International lost money over the twelve months to Aug 31, 2026 (diluted EPS -$0.24), so it has no meaningful P/E ratio.
How much revenue does Cryo-Cell International make?
Cryo-Cell International reported revenue of $31.13M for the twelve months to Aug 31, 2026, down 2.0% from a year earlier.
Does Cryo-Cell International pay a dividend?
No. Cryo-Cell International has not paid a cash dividend over the last twelve months.
How has CCEL stock performed over the past year?
Including dividends, CCEL returned +33.3% over the past year, against +12.0% for the S&P 500.
How many CCEL shares are sold short?
0M shares were sold short at the latest FINRA report, 0.26% of the float, or 1.4 days of average trading volume.
Who are Cryo-Cell International's competitors?
Companies most similar to Cryo-Cell International by business, industry and size include NIVF, MRAI, MCTA, CELU, PFHO.
See a number that looks wrong?